Barbara Schenk

2.4k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Barbara Schenk is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Barbara Schenk has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Barbara Schenk's work include Glycosylation and Glycoproteins Research (7 papers), Carbohydrate Chemistry and Synthesis (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Barbara Schenk is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Carbohydrate Chemistry and Synthesis (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Barbara Schenk collaborates with scholars based in Germany, Switzerland and Belgium. Barbara Schenk's co-authors include Simone Fulda, Charles J. Waechter, Fabiana Fernández, Markus Aebi, Michael Karin, Isolde Pfeuffer, Rolf Swoboda, Edgar Serfling, Frank Mercurio and Eric G. Berger and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Barbara Schenk

26 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

2022 109 citations Alexander Wilhelm, Marek Widera et al. EBioMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Schenk Germany	17	1.1k	427	248	210	192	26	1.5k
Andreas Schröder Germany	18	784 0.7×	609 1.4×	179 0.7×	112 0.5×	273 1.4×	32	1.7k
Gabriella Miklóssy United States	19	675 0.6×	511 1.2×	105 0.4×	172 0.8×	296 1.5×	28	1.5k
Hidesuke Fukazawa Japan	23	882 0.8×	235 0.6×	131 0.5×	163 0.8×	329 1.7×	50	1.6k
Jijun Cheng United States	24	1.1k 1.1×	188 0.4×	403 1.6×	109 0.5×	217 1.1×	32	1.6k
Mutsuhiko Minami Japan	22	630 0.6×	537 1.3×	137 0.6×	117 0.6×	136 0.7×	51	1.5k
Maria Cristina Dechecchi Italy	24	836 0.8×	162 0.4×	250 1.0×	66 0.3×	213 1.1×	35	1.6k
Jason D. Katz United States	12	946 0.9×	994 2.3×	136 0.5×	335 1.6×	213 1.1×	23	1.9k
Ramesh B. Batchu United States	25	1.0k 1.0×	415 1.0×	199 0.8×	51 0.2×	446 2.3×	55	1.7k
Hiroeki Sahara Japan	24	1.1k 1.0×	439 1.0×	329 1.3×	168 0.8×	308 1.6×	76	1.6k
Hanjie Yu China	20	923 0.9×	360 0.8×	79 0.3×	152 0.7×	122 0.6×	82	1.4k

Countries citing papers authored by Barbara Schenk

Since Specialization

Citations

This map shows the geographic impact of Barbara Schenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Schenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Schenk more than expected).

Fields of papers citing papers by Barbara Schenk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Schenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Schenk. The network helps show where Barbara Schenk may publish in the future.

Co-authorship network of co-authors of Barbara Schenk

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Schenk. A scholar is included among the top collaborators of Barbara Schenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Schenk. Barbara Schenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kohmer, Niko, Barbara Schenk, Katharina Grikscheit, et al.. (2022). Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study. International Journal of Infectious Diseases. 128. 166–175. 5 indexed citations

2.

Lehrnbecher, Thomas, Ulrich Sack, Carsten Speckmann, et al.. (2022). Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer. Clinical Infectious Diseases. 76(3). e510–e513. 11 indexed citations

3.

Wilhelm, Alexander, Marek Widera, Katharina Grikscheit, et al.. (2022). Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies. EBioMedicine. 82. 104158–104158. 109 indexed citations breakdown →

4.

Hoehl, Sebastian, Tuna Toptan, Barbara Schenk, et al.. (2022). Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination. SHILAP Revista de lepidopterología. 3. 883724–883724. 6 indexed citations

5.

Hoehl, Sebastian, Barbara Schenk, Sandra Westhaus, et al.. (2020). Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany. Clinical Infectious Diseases. 73(9). e3036–e3041. 10 indexed citations

6.

Schenk, Barbara, et al.. (2018). Interferons Transcriptionally Up-Regulate MLKL Expression in Cancer Cells. Neoplasia. 21(1). 74–81. 40 indexed citations

7.

Schenk, Barbara, et al.. (2017). Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death. Biochemical Pharmacology. 140. 41–52. 148 indexed citations

8.

Schenk, Barbara & Simone Fulda. (2015). Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death. Oncogene. 34(47). 5796–5806. 200 indexed citations

9.

Schenk, Barbara, et al.. (2014). Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death. Oncogene. 34(31). 4032–4043. 35 indexed citations

10.

Laukens, Bram, Barbara Schenk, Nele Vanlangenakker, et al.. (2011). Smac Mimetic Bypasses Apoptosis Resistance in FADD- or Caspase-8-Deficient Cells by Priming for Tumor Necrosis Factor α-Induced Necroptosis. Neoplasia. 13(10). 971–IN29. 86 indexed citations

11.

Bruins, Marjan J., et al.. (2003). Detection of a nosocomial outbreak of salmonellosis may be delayed by application of a protocol for rejection of stool cultures. Journal of Hospital Infection. 54(2). 93–98. 19 indexed citations

12.

Schenk, Barbara, Timo Imbach, Christian Frank, et al.. (2001). MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. Journal of Clinical Investigation. 108(11). 1687–1695. 104 indexed citations

13.

Schenk, Barbara, Timo Imbach, Christian Frank, et al.. (2001). MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. Journal of Clinical Investigation. 108(11). 1687–1695. 33 indexed citations

14.

Schenk, Barbara, Jeffrey S. Rush, Charles J. Waechter, & Markus Aebi. (2001). An alternative cis-isoprenyltransferase activity in yeast that produces polyisoprenols with chain lengths similar to mammalian dolichols. Glycobiology. 11(1). 89–98. 40 indexed citations

15.

Schenk, Barbara, Fabiana Fernández, & Charles J. Waechter. (2001). The ins(ide) and outs(ide) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum. Glycobiology. 11(5). 61R–70R. 143 indexed citations

16.

Imbach, Timo, Barbara Schenk, Els Schollen, et al.. (2000). Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. Journal of Clinical Investigation. 105(2). 233–239. 130 indexed citations

17.

Imbach, Timo, Barbara Schenk, Patricie Burda, et al.. (2000). Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic. Human Genetics. 106(5). 538–545. 57 indexed citations

18.

Otto, Hans‐Uwe, Heinz‐Hermann Krüger, Hans Merkens, et al.. (2000). Datenreport Erziehungswissenschaft. VS Verlag für Sozialwissenschaften eBooks. 5 indexed citations

19.

Cate, Hugo Ten, Barbara Schenk, Bart J. Biemond, et al.. (1994). A review of studies of the activation of the blood coagulation mechanism in chimpanzees (Pan troglodytes). Journal of Medical Primatology. 23(5). 280–284. 2 indexed citations

20.

Schenk, Barbara. (1980). Cannogenol-3-O-_ -rhamnoside and cannogenol-3-O-_ -allomethyloside, two new cardiac glycosides from Convallaria majalis. Planta Medica. 40. 1–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact